Back to Search Start Over

Immunotoxins to the HER-2 oncogene product: functional and ultrastructural analysis of their cytotoxic activity

Authors :
Lazzaro, Claudia Di
Digiesi, Giovanna
Tecce, Raffaele
Lotti, Lavinia V.
Torrisi, Maria Rosaria
Natali, Pier G.
Source :
Cancer Immunology, Immunotherapy; 19941101, Vol. 39 Issue: 5 p318-324, 7p
Publication Year :
1994

Abstract

Two immunotoxins were prepared using monoclonal antibodies (mAb) directed towards two distinct epitopes of the gp185 <superscript>HER-2</superscript> extracellular domain, and the type I ribosome inactivating protein (RIP) plant toxin saporin 6. Cell protein synthesis inhibition assay reveals that the immunotoxins display a potent and specific cytotoxicity that is characterized by a slow rate, since the time required to inhibit incorporation of radiolabeled leucine completely ranges from 36 h to 60 h depending on the target cell line and the immunotoxin. Because this feature may hamper the immunotherapeutic use of these conjugates we analysed this further by studying the early phases of internalization of immunotoxins by immunoelectron microscopy. The results of this study have demonstrated that the distribution pattern of the immunotoxins and of the unconjugated mAb over the cell surface overlaps. Similarly the mAb and immunotoxins are internalized into the cell by two different pathways: via clathrin-coated pits or via smaller uncoated pits and vesicles. A higher degree of internalization is achieved when the two immunotoxins are used in combination. Unlike the slow kinetics of cell intoxication the process of immunotoxin endocytosis is characterized by a rapid rate of internalization (above 40% at 5 min in the SK-BR-3 cell line). Although these findings provide no clue to explain the mechanisms of the slow rate of cytotoxicity of the two immunotoxins their rapid internalization indicates that these reagents can be exploited in immunotherapeutic approches to gp185 <superscript>HER-2</superscript>-expressing malignancies.

Details

Language :
English
ISSN :
03407004 and 14320851
Volume :
39
Issue :
5
Database :
Supplemental Index
Journal :
Cancer Immunology, Immunotherapy
Publication Type :
Periodical
Accession number :
ejs15246487
Full Text :
https://doi.org/10.1007/s002620050132